Anti-GNAS3/ GNAS2/ ALEX monoclonal antibody
Anti-GNAS3/ GNAS2/ ALEX antibody for FACS & in-vivo assay
Go to GNAS/GNAS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP2144-Ab-1/ GM-Tg-hg-MP2144-Ab-2 | Anti-Human GNAS monoclonal antibody | Human |
GM-Tg-rg-MP2144-Ab-1/ GM-Tg-rg-MP2144-Ab-2 | Anti-Rat GNAS monoclonal antibody | Rat |
GM-Tg-mg-MP2144-Ab-1/ GM-Tg-mg-MP2144-Ab-2 | Anti-Mouse GNAS monoclonal antibody | Mouse |
GM-Tg-cynog-MP2144-Ab-1/ GM-Tg-cynog-MP2144-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GNAS monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP2144-Ab-1/ GM-Tg-felg-MP2144-Ab-2 | Anti-Feline GNAS monoclonal antibody | Feline |
GM-Tg-cang-MP2144-Ab-1/ GM-Tg-cang-MP2144-Ab-2 | Anti-Canine GNAS monoclonal antibody | Canine |
GM-Tg-bovg-MP2144-Ab-1/ GM-Tg-bovg-MP2144-Ab-2 | Anti-Bovine GNAS monoclonal antibody | Bovine |
GM-Tg-equg-MP2144-Ab-1/ GM-Tg-equg-MP2144-Ab-2 | Anti-Equine GNAS monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP2144-Ab-1/ GM-Tg-hg-MP2144-Ab-2; GM-Tg-rg-MP2144-Ab-1/ GM-Tg-rg-MP2144-Ab-2; GM-Tg-mg-MP2144-Ab-1/ GM-Tg-mg-MP2144-Ab-2; GM-Tg-cynog-MP2144-Ab-1/ GM-Tg-cynog-MP2144-Ab-2; GM-Tg-felg-MP2144-Ab-1/ GM-Tg-felg-MP2144-Ab-2; GM-Tg-cang-MP2144-Ab-1/ GM-Tg-cang-MP2144-Ab-2; GM-Tg-bovg-MP2144-Ab-1/ GM-Tg-bovg-MP2144-Ab-2; GM-Tg-equg-MP2144-Ab-1/ GM-Tg-equg-MP2144-Ab-2 |
Products Name | Anti-GNAS monoclonal antibody |
Format | mab |
Target Name | GNAS |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GNAS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species GNAS3/ GNAS2/ ALEX VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMAP000010 | Human GNAS Adenovirus plasmid |
ORF Viral Vector | vGMAP000011 | Human GNAS Adenovirus particle |
ORF Viral Vector | vGMAP000010 | Human GNAS Adenovirus particle |
ORF Viral Vector | vGMAP000061 | Human GNAS Adenovirus particle |
ORF Viral Vector | pGMAP000011 | Human GNAS Adenovirus plasmid |
ORF Viral Vector | vGMLP003886 | human GNAS Lentivirus particle |
ORF Viral Vector | pGMAP000061 | Human GNAS Adenovirus plasmid |
ORF Viral Vector | pGMLP003886 | human GNAS Lentivirus plasmid |
Target information
Target ID | GM-MP2144 |
Target Name | GNAS |
Gene ID | 2778,14683,24896,281793 |
Gene Symbol and Synonyms | 5530400H20Rik,A930027G11Rik,AHO,ALEX,C130027O20Rik,C20orf45,G-alpha-8,Galphas,GNAS,GNAS1,Gnasxl,Gnpas,GPSA,Gs-alpha,GSA,GSP,NESP,Nesp55,Nespl,Oed-Sml,Oedsml,P1,P2,P3,PHP1A,PHP1B,PITA3,POH,SCG6,SgVI |
Uniprot Accession | O95467, P63092, P84996, Q5JWF2,P63095,Q63803,Q792G6,Q9Z213,P63091,O18979,P04896 |
Uniprot Entry Name | GNAS2_RAT,GNAS1_RAT,GNAS3_RAT,ALEX_RAT,GNAS_CANLF,GNAS3_BOVIN,GNAS2_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000087460 |
Target Classification | Tumor-associated antigen (TAA) |
The target: GNAS, gene name: GNAS, also named as AHO, C20orf451, GPSA, GSA, GSP, NESP, PITA3, POH, SCG6, SgVI, GNAS. This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.